Yes — and this deserves more attention than it usually gets, because niacin is cheap, sold over the counter, and often self-dosed at levels far above nutritional requirements. Adult daily niacin requirements sit around 14–16 mg; the doses people take for cholesterol or NAD+ purposes are often 1,000–3,000 mg, a 100-fold difference.
Liver injury is the best-documented serious risk. Niacin can cause mild liver enzyme elevations that usually resolve on their own, but serious hepatotoxicity also occurs. It's particularly associated with high doses of sustained-release formulations, and injury often becomes apparent after a dose increase or after switching from regular crystalline to sustained-release forms. Older clinical literature reported jaundice in around 3% of patients on nicotinic acid for a year or more. Case reports document severe outcomes — including one published case of a patient who developed acute decompensated cirrhosis after self-initiated large quantities of extended-release niacin and died during hospitalization. Notably, the timeline of niacin liver injury is unpredictable, ranging from days to years.
The 4PY finding is a newer and important concern. Cleveland Clinic researchers identified a metabolite called 4PY, formed when the body processes excess niacin, that is associated with increased cardiovascular events. Their team reported that roughly 1 in 4 people in both US and European cohorts had 4PY levels high enough to correspond to a doubling of risk for heart attack, stroke, or death, and that 4PY directly promotes vascular inflammation. This helps explain the long-standing "niacin paradox" — that niacin lowers LDL cholesterol but hasn't reliably reduced cardiovascular events in trials.
Other documented effects at high doses include worsening of blood sugar control (relevant if you have or are at risk for diabetes), precipitation of gout in susceptible people, blurred vision, and abdominal discomfort. Clinical guidance suggests checking uric acid, blood glucose, and liver enzymes every 6–8 weeks until a niacin dose is stabilized.
Bottom line: niacin is not a casual "it's just a vitamin" supplement at NAD+-boosting doses. The extended-release forms carry the highest liver risk, and the 4PY data raises real questions about whether pushing B3 intake far above requirements is wise. Niacin is no longer generally recommended for cholesterol management because safer, more effective options exist.
This is squarely a "talk to your doctor" area — especially if you have liver disease, diabetes, gout, or take statins or other lipid medications. Periodic bloodwork is genuinely warranted if you're using high-dose niacin long-term.
Sources for this question:
- NCBI LiverTox, "Niacin" — https://www.ncbi.nlm.nih.gov/books/NBK548176/
- Journal of Investigative Medicine High Impact Case Reports, "Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin" — https://journals.sagepub.com/doi/10.1177/23247096231224349
- Cleveland Clinic, "How Too Much Niacin Can Raise Your Risk of Heart Attack and Stroke" — https://health.clevelandclinic.org/can-niacin-be-harmful-to-control-cholesterol
- Ferrell M, et al., "A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk," Nature Medicine 2024 — doi:10.1038/s41591-023-02793-8
- MSD Manual Professional Edition, "Niacin Toxicity" — https://www.msdmanuals.com/professional/nutritional-disorders/vitamin-deficiency-dependency-and-toxicity/niacin-toxicity
0 comments